Albatroz Therapeutics
PrivateLast Round
Seed
Apr 25, 2023
Total Funding Raised
$3M
Company Overview
Albatroz Therapeutics is a biotechnology company developing first-in-class antibody therapeutics to treat solid tumors and arthritic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Albatroz Therapeutics Comparables
Compare Albatroz Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Matrisome Bio | 78% | |
| Engitix Therapeutics | 76% | |
| BeOne Medicines | 59% |
Albatroz Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 25, 2023 |
Albatroz Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SEEDS Capital | Seed |
| Outram Bio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 98% MoM.
- Jan 22, 2025
Recognized on the 'leading biotech companies in Singapore 2025' list.
Albatroz Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Albatroz Therapeutics's valuation, stock price, and market status.
Is Albatroz Therapeutics a public or private company?
Albatroz Therapeutics is a private company.
What is the current stock price of Albatroz Therapeutics?
Albatroz Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Albatroz Therapeutics worth (valuation)?
Valuation information for Albatroz Therapeutics is not publicly available.
Can I buy Albatroz Therapeutics stock?
Albatroz Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Albatroz Therapeutics's last funding round?
Albatroz Therapeutics's most recent funding round was Seed on April 25, 2023.
Who are the main investors in Albatroz Therapeutics?
Key investors in Albatroz Therapeutics include SEEDS Capital, Outram Bio.
Will Albatroz Therapeutics IPO soon?
No public IPO plans have been announced for Albatroz Therapeutics.
How can I track Albatroz Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Albatroz Therapeutics's secondary market activity and sign up for updates.